Thrasos secures $35M for THR-184 phase II program for acute kidney injury October 26, 2012 CenterWatch Staff
Shire’s Angus Russell to retire in 2013, Ornskov to succeed as CEO October 26, 2012 CenterWatch Staff
AstraZeneca, Ironwood announce linaclotide collaboration for China October 26, 2012 CenterWatch Staff